Exact Mass: 351.992

Exact Mass Matches: 351.992

Found 21 metabolites which its exact mass value is equals to given mass value 351.992, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-(2,4-Dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone

3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one

C15H10Cl2N2O2S (351.984)


   

6-hydroxymethyl-dihydropterin diphosphate

6-({[hydroxy(phosphonooxy)phosphoryl]oxy}methyl)-2-imino-1,2,7,8-tetrahydropteridin-4-olate

C7H8N5O8P2 (351.9848)


6-hydroxymethyl-dihydropterin pyrophosphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). 6-hydroxymethyl-dihydropterin pyrophosphate can be found in a number of food items such as black huckleberry, chickpea, chinese chives, and annual wild rice, which makes 6-hydroxymethyl-dihydropterin pyrophosphate a potential biomarker for the consumption of these food products. 6-hydroxymethyl-dihydropterin pyrophosphate exists in E.coli (prokaryote) and yeast (eukaryote).

   

O1-(2,2,2-Trichlor-1,1-dimethyl-aethyl)-beta-D-glucopyranuronsaeure|O1-(2,2,2-trichloro-1,1-dimethyl-ethyl)-beta-D-glucopyranuronic acid

O1-(2,2,2-Trichlor-1,1-dimethyl-aethyl)-beta-D-glucopyranuronsaeure|O1-(2,2,2-trichloro-1,1-dimethyl-ethyl)-beta-D-glucopyranuronic acid

C10H15Cl3O7 (351.9883)


   

O1-((Xi)-2,2,3-Trichlor-butyl)-beta-D-glucopyranuronsaeure|O1-((Xi)-2,2,3-trichloro-butyl)-beta-D-glucopyranuronic acid

O1-((Xi)-2,2,3-Trichlor-butyl)-beta-D-glucopyranuronsaeure|O1-((Xi)-2,2,3-trichloro-butyl)-beta-D-glucopyranuronic acid

C10H15Cl3O7 (351.9883)


   

Methyl 4-acetoxy-7-bromo-8-methoxy-2-naphthoate

Methyl 4-acetoxy-7-bromo-8-methoxy-2-naphthoate

C15H13BrO5 (351.9946)


   

Methyl 4-acetoxy-8-bromo-5-methoxy-2-naphthoate

Methyl 4-acetoxy-8-bromo-5-methoxy-2-naphthoate

C15H13BrO5 (351.9946)


   

7-Chloro-N-(3-chloro-4-fluorophenyl)-6-nitroquinazolin-4-amine

7-Chloro-N-(3-chloro-4-fluorophenyl)-6-nitroquinazolin-4-amine

C14H7Cl2FN4O2 (351.993)


   

5-(2-bromothiophen-3-yl)-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one

5-(2-bromothiophen-3-yl)-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one

C13H13BrN4OS (351.9993)


   

3-Bromo-6-(phenylsulfonyl)-5,6,7,8-tetrahydro-1,6-naphthyridine

3-Bromo-6-(phenylsulfonyl)-5,6,7,8-tetrahydro-1,6-naphthyridine

C14H13BrN2O2S (351.9881)


   

1H,7H-PERFLUOROHEPTANE 97

1H,7H-PERFLUOROHEPTANE 97

C7H2F14 (351.9933)


   

Thymidine,5-deoxy-5-iodo-

Thymidine,5-deoxy-5-iodo-

C10H13IN2O4 (351.992)


   

sodium,2-[(5E)-5-[(1E)-1-(3-methyl-1,3-thiazolidin-2-ylidene)propan-2-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetate

sodium,2-[(5E)-5-[(1E)-1-(3-methyl-1,3-thiazolidin-2-ylidene)propan-2-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetate

C12H13N2NaO3S3 (351.9986)


   

1-(4-Iodophenyl)-2-(2-methoxyphenyl)ethanone

1-(4-Iodophenyl)-2-(2-methoxyphenyl)ethanone

C15H13IO2 (351.996)


   

2-(2-Chloroacetamido)-5-nitro-2-chlorobenzophenone

2-(2-Chloroacetamido)-5-nitro-2-chlorobenzophenone

C15H10Cl2N2O4 (352.0018)


   

Sodium furosemide

Sodium furosemide

C12H10ClN2NaO5S (351.9897)


Furosemide sodium is a potent and orally active inhibitor of Na+/K+/2Cl-?(NKCC) cotransporter, NKCC1 and NKCC2[1].?Furosemide sodium is also a GABAA?receptors antagonist and displays 100-fold selectivity for?α6-containing receptors than?α1-containing receptors. Furosemide sodium acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema[2].

   

Clorazepate monopotassium

Clorazepate monopotassium

C16H10ClKN2O3 (352.0017)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

(7,8-Dihydropterin-6-yl)methyl diphosphate

(7,8-Dihydropterin-6-yl)methyl diphosphate

C7H8N5O8P2-3 (351.9848)


   

6-hydroxymethyl-dihydropterin diphosphate

6-hydroxymethyl-dihydropterin diphosphate

C7H8N5O8P2-3 (351.9848)


   

5-(2,4-dichlorophenyl)-N-(4-methyl-2-thiazolyl)-2-furancarboxamide

5-(2,4-dichlorophenyl)-N-(4-methyl-2-thiazolyl)-2-furancarboxamide

C15H10Cl2N2O2S (351.984)


   

(2-amino-4-hydroxy-7,8-dihydropteridin-6-yl)methyl diphosphate(3-)

(2-amino-4-hydroxy-7,8-dihydropteridin-6-yl)methyl diphosphate(3-)

C7H8N5O8P2 (351.9848)


Trianion of (2-amino-4-hydroxy-7,8-dihydropteridin-6-yl)methyl diphosphate arising from deprotonation of the three diphosphate OH groups.

   

(7,8-dihydropterin-6-yl)methyl diphosphate(3-)

(7,8-dihydropterin-6-yl)methyl diphosphate(3-)

C7H8N5O8P2 (351.9848)


An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of (7,8-dihydropterin-6-yl)methyl diphosphate.